Design, Synthesis, and Biological Evaluation of Novel Thioureidobenzamide (TBA) Derivatives as HBV Capsid Assembly Modulators.

Hepatitis B virus (HBV) capsid assembly modulators (CAMs) represent a promising therapeutic approach for the treatment of HBV infection. In this study, we designed and synthesized five series of benzamide derivatives based on a multisite-binding strategy at the tolerant region and diversity modification in the solvent-exposed region. Among them, thioureidobenzamide compound exhibited significantly increased anti-HBV activity in HepAD38 (EC = 0.

Design, synthesis and biological evaluation of novel dihydrobenzodioxine derivatives as HBV capsid protein inhibitors.

Capsid assembly modulators (CAMs) have recently been revealed to be effective in blocking HBV replication. HBV capsid protein inhibitors reduce and ultimately eliminate HBV by inhibiting virus replication and blocking hepatocyte infection. Sulfonamides are synthetic functional groups in development of different kinds of drugs.

[Pilot Study on Start-up and Stable Operation at Low Temperature Based on Denitrifying Phosphorus Removal].

In order to understand the denitrifying and phosphorus removal characteristics of denitrifying phosphate-accumulating organisms (DPAOs), a pilot scale (20 m) denitrifying and phosphorus removal experiment was carried out using a modified University of Cape Town (UCT) process at low temperatures of (6-16)℃. The test results show that at such temperatures, the hydraulic retention time (HRT) is 20 h and the solids retention time (SRT) is 35 days, and the modified UCT process can start up successfully and run steadily. When running steadily, the system can maintain nitrogen and phosphorus removal rates of 60%±5% and 80%±5%, respectively.